Association of Fibroblast Growth Factor 23 and Calcium in Chronic Kidney Disease Patients

Association of Fibroblast Growth Factor 23 and Calcium in Chronic Kidney Disease Patients

Chronic kidney disease (CKD) is a growing international health concern with elevating mortality rate in the world today and it is generally a progressive and irreversible issue. It is defined by changes in kidney shape, function, or both lasting at least three months. Renal disease is commonly asso...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ghaith Hamza Kamil, Mohammed Mezher Hussein, Raya Ezzat Maroof
Format:	Article
Language:	English
Published:	middle technical university 2022-11-01
Series:	Journal of Techniques
Subjects:	Chronic kidney disease Calcium Fibroblast growth factor 23
Online Access:	https://journal.mtu.edu.iq/index.php/MTU/article/view/656
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correlation of serum fibroblast growth factor-23 levels and calcium phosphate products levels in chronic kidney disease; sub analysis of chronic kidney disease-mineral and bone disorder study
by: Adeh Mahardika, et al.
Published: (2024-08-01)

Correlation of Fibroblast Growth Factor-23 with Thyroid Disorder in Patients with Chronic Kidney Disease
by: Abdullah Adil Raoof, et al.
Published: (2025-01-01)

The relationship between serum level of fibroblast growth factor 23 and valvular calcification in chronic kidney disease patients
by: XU Feng-bo, et al.
Published: (2015-01-01)

The prognostic and diagnostic value of fibroblast growth factor 23 in patients undergoing hemodialysis
by: Vladyslav Bardash, et al.
Published: (2025-06-01)

Role of the fibroblast growth factor type 23 in progression of complications and imbalance of calcium-phosphoric metabolism with patients suffering chronic kidney disease
by: A. M. Yesayan, et al.
Published: (2015-03-01)

Correlation of fibroblast growth factor 23 gene polymorphism with susceptibility of diabetic kidney disease
by: CAO Jing-wen, et al.
Published: (2019-01-01)

Fibroblast Growth Factor 23 Measurement in the Serum of Patients on Hemodialysis in Erbil Kidney Diseases and Dialysis Department
by: Majeed Hassan Shekhany, et al.
Published: (2023-04-01)

Research Progress on correlation of fibroblast growth factor 23 and klotho with vascular calcification
by: FU Qian-li, et al.
Published: (2019-01-01)

Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease
by: Katarzyna Muras-Szwedziak, et al.
Published: (2023-12-01)

Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients
by: Riri Andri Muzasti, et al.
Published: (2021-01-01)

Baseline fibroblast growth factor 23 predicts incident heart failure and cardiovascular mortality in patients with chronic kidney disease: A 3-year follow-up study
by: Ying Wang, et al.
Published: (2025-02-01)

Evaluating the Fibroblast Growth Factor-23 and Phosphate in Iraqi Patients with Acromegaly
by: Sara A. Kashash, et al.
Published: (2024-03-01)

Predictive value of circulating fibroblast growth factor-23 and Klotho on protein-energy wasting in patients undergoing hemodialysis
by: Xiaoling Zhou, et al.
Published: (2025-01-01)

Serum Fibroblast Growth Factor 23 Levels as a Predictor of Acute Kidney Injury in Critically Ill Obstetric Women in Obstetric Intensive Care Units: A North Indian Study
by: Munna Lal Patel, et al.
Published: (2025-06-01)

Correlation linking fibroblast growth factor 23 in circulation (FGF-23) and serum aldosterone levels in different stages of chronic kidney disease
by: Amira Hassan Elsaid Dohuim, et al.
Published: (2025-03-01)

Role of serum fibroblast growth factor-23 and Klotho level in COVID-19 infection-related mortality: a prospective study
by: Davut Akin, et al.
Published: (2024-12-01)

The Severity of Carotid Calcifications, but Not Fibroblast Growth Factor 23, Is Associated with Mortality in Hemodialysis: A Single Center Experience
by: Diana Moldovan
Published: (2025-02-01)

Expression profile of FGF23, alpha klotho, microRNA-126, and wnt signaling pathway gene polymorphism in patients with acute or chronic kidney diseases: relation to dialysis requirements
by: Mohammed H. Hassan, et al.
Published: (2025-01-01)

The significance of plasma fibroblast growth factor 23 in predicting acute renal injury in rats
by: 胡蓉, et al.
Published: (2019-01-01)

Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
by: S. S. Rodionova, et al.
Published: (2019-12-01)

The importance of whey protein levels of Klotho and fibroblast growth of factor-23 (fgf-23) as early diagnostic markers of chronic kidney damage
by: L. Yu. Milovanova, et al.
Published: (2014-06-01)

Tumor-Induced Osteomalacia in a Patient With FGF23-Amplified Lung Adenocarcinoma and FGF23-Deleted SCLC: Case Report
by: Marcello Moro Queiroz, MD, et al.
Published: (2025-06-01)

Adipose tissue-associated Krt23+fibroblasts contribute to immune microenvironment disorders in mouse adipose tissue during the development of obesity
by: Zhimin Lu, et al.
Published: (2025-08-01)

FGF23-related hypophosphatemia in a patient with small cell lung cancer: a case report and literature review
by: Hajime Kato, et al.
Published: (2023-10-01)

Gucy1α1 specifically marks kidney, heart, lung and liver fibroblasts
by: Valeria Rudman-Melnick, et al.
Published: (2024-11-01)

An unusual cause of osteomalacia in a young lady
by: Angan Karmakar, et al.
Published: (2024-05-01)

The Association of b2-Microglobulin and Fibroblast Growth Factor 23 with Major Adverse Cardiac Event in Acute Coronary Syndrome Patients with Chronic Kidney Disease
by: Eka Ginanjar, et al.
Published: (2021-03-01)

The Association of b2-Microglobulin and Fibroblast Growth Factor 23 with Major Adverse Cardiac Event in Acute Coronary Syndrome Patients with Chronic Kidney Disease
by: Eka Ginanjar, et al.
Published: (2021-03-01)

Evaluation of fibroblast growth factor 23 as a marker of severity in stable chronic obstructive pulmonary disease
by: Simarpreet Singh, et al.
Published: (2025-06-01)

ELABORATION OF METHOD FOR GRADIENT AND ACTIVE CALCIUM RENAL REABSORBTION DEFINITION FOR FUNCTIONAL ESTIMATION OF TRANSPLANTED KIDNEY
by: I. P. Yermakova, et al.
Published: (2010-06-01)

Phosphaturic Mesenchymal Tumor of Tibia: A Challenging Diagnosis Rendered on Percutaneous Core Needle Biopsy
by: Monalisa Hui, et al.

Fibroblast Growth Factor 23 and Sarcopenia in Maintenance Haemodialysis Population
by: Limy Wong, et al.
Published: (2025-06-01)

Correlation between serum magnesium and calcium ions and peripheral nerve function in chronic kidney disease
by: Zuo Xiao-li, et al.
Published: (2021-01-01)

The Role of Fibroblast Growth Factor Receptors Inhibitors in Bladder Cancer
by: Ho Kyung Seo, et al.
Published: (2024-07-01)

Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
by: Mohamed Faher Almahmoud, et al.
Published: (2018-09-01)

Tumor-induced phosphopenic osteomalacia: modern approaches to diagnostics and treatment
by: A. A. Kondrashov, et al.
Published: (2024-10-01)

Expression of FGF23 and α-KLOTHO in Normal Human Kidney Development and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
by: Patricija Bajt, et al.
Published: (2025-06-01)

Serum FGF-23 and Vitamin D Deficiency as Predictors of Metabolic Syndrome in Chronic Kidney Disease
by: Tazeen Shah, et al.
Published: (2025-04-01)

The Effect of Ferric Carboxymaltose on Fibroblast Growth Factor 23 (FGF23) in Children with Iron Deficiency Anemia Due to Gastrointestinal Diseases
by: Maria Ntoumpara, et al.
Published: (2024-11-01)

Hypoxia Activates FGF-23-ERK/MAPK Signaling Pathway in Ischemia-Reperfusion-Induced Acute Kidney Injury
by: Weihua Liu, et al.
Published: (2024-10-01)